These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35154668)

  • 1. Mucormycosis and COVID-19: Double trouble for India?
    Yasmin F; Najeeb H; Siddiqui SA; Ochani RK
    J Glob Health; 2022; 12():03001. PubMed ID: 35154668
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 and Mucormycosis in India a Study on Implicated Risk Factors.
    Deepak P; Rao MR; Mandadi K
    J Assoc Physicians India; 2022 May; 70(5):11-12. PubMed ID: 35598140
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors.
    Arakeri G; Patil S; Rao Us V; Amaral Mendes R; Oeppen RS; Brennan PA
    Br J Oral Maxillofac Surg; 2022 May; 60(4):e533-e534. PubMed ID: 35351328
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
    Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
    Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucormycosis Epidemic and Stroke in India During the COVID-19 Pandemic.
    Padma Srivastava MV; Vishnu VY; Pandit AK
    Stroke; 2021 Oct; 52(10):e622-e623. PubMed ID: 34525840
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 associated mucormycosis (CAM) in India: a formidable challenge.
    Rao VUS; Arakeri G; Madikeri G; Shah A; Oeppen RS; Brennan PA
    Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1095-1098. PubMed ID: 34507870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "Black Fungus" in India: The Emerging Syndemic of COVID-19-Associated Mucormycosis.
    Gandra S; Ram S; Levitz SM
    Ann Intern Med; 2021 Sep; 174(9):1301-1302. PubMed ID: 34097436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Mucormycosis and COVID-19.
    Yadav S
    J Contemp Dent Pract; 2021 Aug; 22(8):855. PubMed ID: 34753834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Epidemic of Mucormycosis Coinciding With the COVID-19 Pandemic in India.
    MohanaSundaram A; Thukani Sathanantham S; Kulkarni A; Kulkarni S; Chinchole V; Patil B; Velayutham R
    Asia Pac J Public Health; 2022 Mar; 34(2-3):304-305. PubMed ID: 34779277
    [No Abstract]   [Full Text] [Related]  

  • 10. The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?
    Gupta A; Sharma A; Chakrabarti A
    Indian J Ophthalmol; 2021 Jul; 69(7):1645-1647. PubMed ID: 34146000
    [No Abstract]   [Full Text] [Related]  

  • 11. Online Registry of COVID-19-Associated Mucormycosis Cases, India, 2021.
    Arora S; Hemmige VS; Mandke C; Chansoria M; Rawat SK; Dravid A; Sethi Y; Medikeri G; Jariwala SP; Puius YA;
    Emerg Infect Dis; 2021; 27(11):2963-2965. PubMed ID: 34586056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mucormycosis epidemic within COVID-19 pandemic- lessons from India.
    Jy Ong J; Cy Chan A; Sharma AK; Sharma S; Sharma VK
    Brain Behav Immun; 2021 Oct; 97():4-5. PubMed ID: 34371133
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications of the second wave of COVID-19 in India.
    Asrani P; Eapen MS; Hassan MI; Sohal SS
    Lancet Respir Med; 2021 Sep; 9(9):e93-e94. PubMed ID: 34216547
    [No Abstract]   [Full Text] [Related]  

  • 14. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
    Singh AK; Singh R; Joshi SR; Misra A
    Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?
    Raut A; Huy NT
    Lancet Respir Med; 2021 Aug; 9(8):e77. PubMed ID: 34090607
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 associated mucormycosis - An emerging threat.
    Chao CM; Lai CC; Yu WL
    J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucormycosis: An unanticipated progeny of COVID-19.
    Shrestha GS; Bhandari S; Lamsal R; Gurung U
    JNMA J Nepal Med Assoc; 2021 Sep; 59(241):965-967. PubMed ID: 35199723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can low-dose radiation therapy reduce the risk of mucormycosis in COVID-19 patients?
    Sharma DN; Welsh J; Kumar R
    J Cancer Res Ther; 2021; 17(6):1294-1296. PubMed ID: 34916356
    [No Abstract]   [Full Text] [Related]  

  • 20. The Past, Present and Future of COVID-19 Associated Mucormycosis: A Rapid Review.
    Sarfraz Z; Sarfraz A; Jaiswal V; Poudel S; Bano S; Hanif M; Singh Shrestha P; Sarfraz M; Michel G; Cherrez-Ojeda I
    J Prim Care Community Health; 2022; 13():21501319221099476. PubMed ID: 35587142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.